Mergers and Acquisitions

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

Inversago Pharma
Key Contact
Nathalie Beauregard

Partner, Emerging and High Growth Companies, Montréal

Team
Shahir Guindi, Ad. E.

Former National Co-Chair, Partner, Corporate, Montréal

Sophie Amyot

Partner, Corporate, Montréal

Calvin Leung

Partner, Emerging and High Growth Companies, Montréal

Yulia Yugay

Associate, Corporate, Montréal

Vincent Legault

Associate, Corporate, Montréal

Marc-André Champigny

Associate, Emerging and High Growth Companies, Montréal

Olivier Dufrasne-Desbiens

Associate, Emerging and High Growth Companies, Montréal

Alain Fournier

Partner, Tax, Montréal

Jeremy Perron

Associate, Pensions and Benefits, Montréal

Jean-Philippe Dionne

Associate, Tax, Montréal

 

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and related disorders.

Inversago Pharma is a private and Montreal-based developer of CB1 receptor-based therapies for the potential treatment of obesity, diabetes and complications associated with metabolic disorders.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark.

Osler, Hoskin & Harcourt LLP advised Inversago Pharma with a team consisting of included Nathalie Beauregard, Shahir Guindi , Sophie Amyot , Calvin Leung, Yulia Yugay, Vincent Legault, Marc-André Champigny, Olivier Dufrasne-Desbiens (Corporate), Alain Fournier, Jean-Philippe Dionne (Tax), and  Jeremy Perron (Employment and Labour).

Value
US$1.075 billion
Date Closed
--
Lead Office
Montréal
Key Contact
Nathalie Beauregard

Partner, Emerging and High Growth Companies, Montréal

Team
Shahir Guindi, Ad. E.

Former National Co-Chair, Partner, Corporate, Montréal

Sophie Amyot

Partner, Corporate, Montréal

Calvin Leung

Partner, Emerging and High Growth Companies, Montréal

Yulia Yugay

Associate, Corporate, Montréal

Vincent Legault

Associate, Corporate, Montréal

Marc-André Champigny

Associate, Emerging and High Growth Companies, Montréal

Olivier Dufrasne-Desbiens

Associate, Emerging and High Growth Companies, Montréal

Alain Fournier

Partner, Tax, Montréal

Jeremy Perron

Associate, Pensions and Benefits, Montréal

Jean-Philippe Dionne

Associate, Tax, Montréal